A
C
T
G

The world is
talking about
RNA therapy.

Scroll To Learn More
Press Releases

Shape Therapeutics to Highlight RNA Editing Technology Platform Advancements in Parkinson’s Disease and the Identification of Novel CNS-targeting AAV Variants at the J.P. Morgan 39th Annual Healthcare Conference

1 - 11 - 2021

Shape Therapeutics Announces Appointment of Gary Fortin as Chief Operating Officer

12 - 08 - 2020

Shape Therapeutics Unveils AAVid™ Capsid Discovery Platform and Identification of Novel Tissue-Specific AAV Variants, Solving a Fundamental Delivery Challenge in Gene Therapy

12 - 03 - 2020

ShapeTx to present at the 2nd RNA Editing Summit, Boston MA

11 - 19 - 2020

ShapeTX to present groundbreaking advances in ADAR-Mediated RNA editing in Parkinson’s Disease at the Jefferies Gene Therapy and Editing Summit

10 - 01 - 2020

ShapeTX to present at the BTIG Virtual Biotechnology Conference

8 - 10 - 2020

ShapeTX to present at the SVB Leerink Biopharma Private Company Connect

7 - 07 - 2020

ShapeTX to present at the Oppenheimer Private Life Sciences Company Call Series

6 - 29 - 2020

ShapeTX to present at the Jefferies Virtual Healthcare Conference

6 - 02 - 2020

ShapeTX to present at the 9th Annual SVB Leerink Global Healthcare Conference New York

2 - 25 - 2020

ShapeTX to present at the 1st RNA Editing Summit , Boston MA

11 - 19 - 2019

Shape Therapeutics raises $35.5M in Series A financing.

11 - 05 - 2019
Swipe Left To Learn More
News
Developing A NextGen RNA Therapy for Rett Syndrom
Dec, 16th, 2020.
Read articleDeveloping A NextGen RNA Therapy for Rett Syndrom
ShapeTX Claims Breakthrough in Tissue-Specific Gene Therapies
Dec, 8th, 2020
Read article
8 Innovative Tech Companies to Watch for in 2021
Tech Report- Nov 30th 2020
Read article
Nature Biotechnology’s academic spinouts of 2019
Nature Biotechnology — Apr 23rd 2020
Learn More
7 Innovative Startups to Watch in 2020
Inc.com — Jan 6th 2020
Learn More
ShapeTx: Shaping up RNA editing
Biocentury — Nov 21st 2019
Learn More
As CRISPR horizons cloud, a startup focuses on the next big thing with powerhouse potential—the RNA editing platform
Endpoints News — Nov 5th 2019
Learn More
    Developing A NextGen RNA Therapy for Rett Syndrom
    Dec, 16th, 2020.
    Read articleDeveloping A NextGen RNA Therapy for Rett Syndrom
    ShapeTX Claims Breakthrough in Tissue-Specific Gene Therapies
    Dec, 8th, 2020
    Read article
    8 Innovative Tech Companies to Watch for in 2021
    Tech Report- Nov 30th 2020
    Read article
    Nature Biotechnology’s academic spinouts of 2019
    Nature Biotechnology — Apr 23rd 2020
    Learn More
    7 Innovative Startups to Watch in 2020
    Inc.com — Jan 6th 2020
    Learn More
    ShapeTx: Shaping up RNA editing
    Biocentury — Nov 21st 2019
    Learn More
    As CRISPR horizons cloud, a startup focuses on the next big thing with powerhouse potential—the RNA editing platform
    Endpoints News — Nov 5th 2019
    Learn More
Swipe Left To Learn More
Publications
1 - 13 - 2021

Robust RNA editing via recruitment of endogenous ADARs using circular guide RNAs

9 - 09 - 2020

Comprehensive interrogation of the ADAR2 deaminase domain for engineering enhanced RNA base-editing activity, functionality and specificity

8 - 27 - 2019

Immune-orthogonal Orthologues of AAV Capsids and of Cas9 Circumvent in the Immune Response to the Administration of Gene Therapy

4 - 03 - 2019

RNA-Guided Adenosine Deaminases: Advances and Challenges for Therapeutic RNA Editing

2 - 08 - 2019

In vivo RNA Editing of Point Mutations via RNA-guided Adenosine Deaminases

2 - 26 - 2018

Oligonucleotide Conjugated Multi-Functional Adeno-Associated Viruses

10 - 28 - 2017

In Vivo RNA Targeting of Point Mutations via Suppressor tRNAs and Adenosine Deaminases

Swipe Left To Learn More

Media Kit

Logos

Images

water2

Next:

Therapeutics Platform